In Brief: Alaris Medical
This article was originally published in The Gray Sheet
Executive Summary
Alaris Medical: IVAC Vital Check 4400 portable bedside vital signs monitor is launched in conjunction with partner Criticare, Inc. for the noninvasive measurement of blood pressure, pulse oximetry and temperature. A full product launch is expected in first quarter of 1998, with Alaris holding exclusive distribution to the U.S. hospital market and all Canadian markets. The five-pound unit, which Alaris says may be used to monitor patients ranging from neonates to geriatrics, pairs Alaris' IVAC electronic thermometry technology with Criticare's digital pulse oximetry and noninvasive blood pressure monitors...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.